Market Place
Sourcing Support
Arfolitixorin Lands FDA Fast Track Designation for Advanced CRC
26 Nov 2021 //
TARGETEDONC
Isofol announces licensing agreement for Paladin Labs to arfolitixorin
02 Nov 2020 //
BIOSPACE
Invitation to a conference call & webcast Isofol license agreement Paladin Labs
02 Nov 2020 //
PRNEWSWIRE
ISOFOL ENTERS LICENSING AGREEMENT WITH SOLASIA COMMERCIALIZE ARFOLITIXORIN
17 Aug 2020 //
ISOFOLMEDICAL
Isofol enters licensing agreement with Solasia to develop arfolitixorin in Japan
12 Aug 2020 //
PRNEWSWIRE
Isofol`s Drug Candidate Arfolitixorin Receives Add Clinical Patent Approval
04 May 2020 //
PRNEWSWIRE
The First Patient Included in Japan in Isofol`s Phase 3 AGENT Study
18 Feb 2020 //
PR NEWSWIRE
Copyright © 2024 LePro PharmaCompass OPC Private Limited, All rights reserved.